Repository logo
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Bandopadhyay, Debashree"

Now showing 1 - 1 of 1
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    I32E and V36K double mutation in ß2-sheet abrogates amyloid ß peptide toxicity.
    (2010-11) Subramanian, Sarada; Mishra, Pradeep Kumar; Bandopadhyay, Debashree
    Alzheimer’s disease (AD) is the most common cause of dementia in the elderly, wherein, the accumulation of amyloid ß(Aß) peptide as cytotoxic oligomers leads to neuropathologic changes. Transgenic mice with brain Aß plaques immunizedwith aggregated Aß have reduced amyloid burden and improved cognitive functions. However, such active immunization inhumans led to a small but significant occurrence of meningoencephalitis in 6% AD volunteers due to Aß induced toxicity. Inan attempt to develop safer alternative vaccines, the design of a highly soluble peptide homologous to Aß (Aß-EK), that hasa reduced amyloidogenic potential while maintaining the major immunogenic epitopes of Aß is reported. More importantly,this homologue has been shown to be non-toxic, as this peptide failed to exert any observable effect on erythrocytes. Theresults of the present study suggests that immunization with non-toxic Aß derivative may offer a safer therapeutic approachto AD, instead of using toxic Aß fibrils.

IMSEAR is the collaborative product of Health Literature, Library and Information Services (HELLIS) Network Member Libraries in the WHO South-East Asia Region.
HELLIS is coordinated by WHO Regional Office for South-East Asia.

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback